Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Orbach

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
Annals of the Rheumatic Diseases|October 29, 2010
Vitamin D: an instrumental factor in the anti-phospholipid syndrome by inhibition of tissue factor expressionN Agmon-Levin, M Blank, G Zandman-Goddard, et al.
Annals of the Rheumatic Diseases|May 5, 2010
Serum concentrations of 25-OH vitamin D in patients with systemic lupus erythematosus (SLE) are inversely related to disease activity: is it time to routinely supplement patients with SLE with vitamin D?H Amital, Z Szekanecz, G Szücs, et al.
European Journal of Cancer (Oxford, England : 1990)|December 6, 2021
Localised rhabdomyosarcoma in infants (<12 months) and young children (12-36 months of age) treated on the EpSSG RMS 2005 studyOlga Slater, Jennifer E Gains, Anna M Kelsey, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
Annals of the Rheumatic Diseases|October 29, 2010
Vitamin D: an instrumental factor in the anti-phospholipid syndrome by inhibition of tissue factor expressionN Agmon-Levin, M Blank, G Zandman-Goddard, et al.
Annals of the Rheumatic Diseases|May 5, 2010
Serum concentrations of 25-OH vitamin D in patients with systemic lupus erythematosus (SLE) are inversely related to disease activity: is it time to routinely supplement patients with SLE with vitamin D?H Amital, Z Szekanecz, G Szücs, et al.
European Journal of Cancer (Oxford, England : 1990)|December 6, 2021
Localised rhabdomyosarcoma in infants (<12 months) and young children (12-36 months of age) treated on the EpSSG RMS 2005 studyOlga Slater, Jennifer E Gains, Anna M Kelsey, et al.
Pageof 3